臼井 亮太

最終更新日時: 2019/06/03 15:41:35

印刷する

氏名(漢字/フリガナ/アルファベット表記)
臼井 亮太/ウスイ リョウタ/Usui, Ryota
所属部署・職名(部局/所属/講座等/職名)
医学部附属病院/内科(糖尿病・内分泌・栄養内科)/特定助教
ORCID ID
https://orcid.org/0000-0002-4641-0158
researchmap URL
https://researchmap.jp/ryota_u
論文
著者 著者(日本語) 著者(英語) タイトル タイトル(日本語) タイトル(英語) 書誌情報等 書誌情報等(日本語) 書誌情報等(英語) 出版年月 査読の有無 記述言語 掲載種別 公開
Liu Y, Harashima SI, Wang Y, Suzuki K, Tokumoto S, Usui R, Tatsuoka H, Tanaka D, Yabe D, Harada N, Hayashi Y, Inagaki N Liu Y, Harashima SI, Wang Y, Suzuki K, Tokumoto S, Usui R, Tatsuoka H, Tanaka D, Yabe D, Harada N, Hayashi Y, Inagaki N Liu Y, Harashima SI, Wang Y, Suzuki K, Tokumoto S, Usui R, Tatsuoka H, Tanaka D, Yabe D, Harada N, Hayashi Y, Inagaki N Sphingosine kinase 1-interacting protein is a dual regulator of insulin and incretin secretion. Sphingosine kinase 1-interacting protein is a dual regulator of insulin and incretin secretion. Sphingosine kinase 1-interacting protein is a dual regulator of insulin and incretin secretion. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, fj201801783RR FASEB journal : official publication of the Federation of American Societies for Experimental Biology, fj201801783RR FASEB journal : official publication of the Federation of American Societies for Experimental Biology, fj201801783RR 2019/02 公開
Ryota Usui, Daisuke Yabe, Yutaka Seino Ryota Usui, Daisuke Yabe, Yutaka Seino Ryota Usui, Daisuke Yabe, Yutaka Seino Twincretin as a potential therapeutic for the management of type 2 diabetes with obesity Twincretin as a potential therapeutic for the management of type 2 diabetes with obesity Twincretin as a potential therapeutic for the management of type 2 diabetes with obesity Journal of Diabetes Investigation Journal of Diabetes Investigation Journal of Diabetes Investigation 2019/02 公開
Ryota Usui, Yui Sakuramachi, Yusuke Seino, Kenta Murotani, Hitoshi Kuwata, Hisato Tatsuoka, Yoshiyuki Hamamoto, Takeshi Kurose, Yutaka Seino, Daisuke Yabe Ryota Usui, Yui Sakuramachi, Yusuke Seino, Kenta Murotani, Hitoshi Kuwata, Hisato Tatsuoka, Yoshiyuki Hamamoto, Takeshi Kurose, Yutaka Seino, Daisuke Yabe Ryota Usui, Yui Sakuramachi, Yusuke Seino, Kenta Murotani, Hitoshi Kuwata, Hisato Tatsuoka, Yoshiyuki Hamamoto, Takeshi Kurose, Yutaka Seino, Daisuke Yabe Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target 1 year after init Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target 1 year after init Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β-cell function and the achievement of the HbA1c target 1 year after init Journal of Diabetes Investigation, 9, 4, 981 Journal of Diabetes Investigation, 9, 4, 981 Journal of Diabetes Investigation, 9, 4, 981 2018/07 公開
Kuwata H, Okamoto S, Seino Y, Murotani K, Tatsuoka H, Usui R, Hamamoto Y, Kurose T, Seino Y, Yabe D. Kuwata H, Okamoto S, Seino Y, Murotani K, Tatsuoka H, Usui R, Hamamoto Y, Kurose T, Seino Y, Yabe D. Kuwata H, Okamoto S, Seino Y, Murotani K, Tatsuoka H, Usui R, Hamamoto Y, Kurose T, Seino Y, Yabe D. Relationship between deterioration of glycated hemoglobin-lowering effects in dipeptidyl peptidase-4 inhibitor monotherapy and dietary habits: Retrospective analysis of Japanese individuals with type 2 diabetes Relationship between deterioration of glycated hemoglobin-lowering effects in dipeptidyl peptidase-4 inhibitor monotherapy and dietary habits: Retrospective analysis of Japanese individuals with type 2 diabetes Relationship between deterioration of glycated hemoglobin-lowering effects in dipeptidyl peptidase-4 inhibitor monotherapy and dietary habits: Retrospective analysis of Japanese individuals with type 2 diabetes Journal of Diabetes Investigation Journal of Diabetes Investigation Journal of Diabetes Investigation 2017 公開
Usui R, Sakuramachi Y, Seino Y, Murotani K, Kuwata H, Tatsuoka H, Hamamoto Y, Kurose T, Seino Y, Yabe D. Usui R, Sakuramachi Y, Seino Y, Murotani K, Kuwata H, Tatsuoka H, Hamamoto Y, Kurose T, Seino Y, Yabe D. Usui R, Sakuramachi Y, Seino Y, Murotani K, Kuwata H, Tatsuoka H, Hamamoto Y, Kurose T, Seino Y, Yabe D. Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining β-cell function and the achievement of the glycated hemoglobin target 1 year after initiation Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining β-cell function and the achievement of the glycated hemoglobin target 1 year after initiation Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes patients: The association between remaining β-cell function and the achievement of the glycated hemoglobin target 1 year after initiation Journal of Diabetes Investigation Journal of Diabetes Investigation Journal of Diabetes Investigation 2017 公開
Wang Y, Harashima S.-I, Liu Y, Usui R, Inagaki N. Wang Y, Harashima S.-I, Liu Y, Usui R, Inagaki N. Wang Y, Harashima S.-I, Liu Y, Usui R, Inagaki N. Sphingosine kinase 1-interacting protein is a novel regulator of glucose-stimulated insulin secretion Sphingosine kinase 1-interacting protein is a novel regulator of glucose-stimulated insulin secretion Sphingosine kinase 1-interacting protein is a novel regulator of glucose-stimulated insulin secretion Scientific Reports, 7, 1 Scientific Reports, 7, 1 Scientific Reports, 7, 1 2017 公開
Ogura K, Ogura M, Shoji T, Sato Y, Tahara Y, Yamano G, Sato H, Sugizaki K, Fujita N, Tatsuoka H, Usui R, Mukai E, Fujimoto S, Inagaki N, Nagashima K. Ogura K, Ogura M, Shoji T, Sato Y, Tahara Y, Yamano G, Sato H, Sugizaki K, Fujita N, Tatsuoka H, Usui R, Mukai E, Fujimoto S, Inagaki N, Nagashima K. Ogura K, Ogura M, Shoji T, Sato Y, Tahara Y, Yamano G, Sato H, Sugizaki K, Fujita N, Tatsuoka H, Usui R, Mukai E, Fujimoto S, Inagaki N, Nagashima K. Oral Administration of Apple Procyanidins Ameliorates Insulin Resistance via Suppression of Pro-Inflammatory Cytokine Expression in Liver of Diabetic ob/ob Mice Oral Administration of Apple Procyanidins Ameliorates Insulin Resistance via Suppression of Pro-Inflammatory Cytokine Expression in Liver of Diabetic ob/ob Mice Oral Administration of Apple Procyanidins Ameliorates Insulin Resistance via Suppression of Pro-Inflammatory Cytokine Expression in Liver of Diabetic ob/ob Mice Journal of Agricultural and Food Chemistry, 64, 46, 8857-8865 Journal of Agricultural and Food Chemistry, 64, 46, 8857-8865 Journal of Agricultural and Food Chemistry, 64, 46, 8857-8865 2016 公開
Sato H, Nagashima K, Ogura M, Sato Y, Tahara Y, Ogura K, Yamano G, Sugizaki K, Fujita N, Tatsuoka H, Usui R, Mukai E, Fujimoto S, Inagaki N. Sato H, Nagashima K, Ogura M, Sato Y, Tahara Y, Ogura K, Yamano G, Sugizaki K, Fujita N, Tatsuoka H, Usui R, Mukai E, Fujimoto S, Inagaki N. Sato H, Nagashima K, Ogura M, Sato Y, Tahara Y, Ogura K, Yamano G, Sugizaki K, Fujita N, Tatsuoka H, Usui R, Mukai E, Fujimoto S, Inagaki N. Src regulates insulin secretion and glucose metabolism by influencing subcellular localization of glucokinase in pancreatic β-cells Src regulates insulin secretion and glucose metabolism by influencing subcellular localization of glucokinase in pancreatic β-cells Src regulates insulin secretion and glucose metabolism by influencing subcellular localization of glucokinase in pancreatic β-cells Journal of Diabetes Investigation, 7, 2, 171-178 Journal of Diabetes Investigation, 7, 2, 171-178 Journal of Diabetes Investigation, 7, 2, 171-178 2016 公開
Yabe D, Kuwata H, Usui R, Kurose T, Seino Y. Yabe D, Kuwata H, Usui R, Kurose T, Seino Y. Yabe D, Kuwata H, Usui R, Kurose T, Seino Y. Glucagon-like peptide-1 receptor agonist therapeutics for total diabetes management: Assessment of composite end-points Glucagon-like peptide-1 receptor agonist therapeutics for total diabetes management: Assessment of composite end-points Glucagon-like peptide-1 receptor agonist therapeutics for total diabetes management: Assessment of composite end-points Current Medical Research and Opinion, 31, 7, 1267-1270 Current Medical Research and Opinion, 31, 7, 1267-1270 Current Medical Research and Opinion, 31, 7, 1267-1270 2015 公開
Usui R, Yabe D, Kuwata H, Murotani K, Kurose T, Seino Y. Usui R, Yabe D, Kuwata H, Murotani K, Kurose T, Seino Y. Usui R, Yabe D, Kuwata H, Murotani K, Kurose T, Seino Y. Retrospective analysis of safety and efficacy of liraglutide monotherapy and sulfonylurea-combination therapy in Japanese type 2 diabetes: Association of remaining β-cell function and achievement of HbA1c target one year after initiation Retrospective analysis of safety and efficacy of liraglutide monotherapy and sulfonylurea-combination therapy in Japanese type 2 diabetes: Association of remaining β-cell function and achievement of HbA1c target one year after initiation Retrospective analysis of safety and efficacy of liraglutide monotherapy and sulfonylurea-combination therapy in Japanese type 2 diabetes: Association of remaining β-cell function and achievement of HbA1c target one year after initiation Journal of Diabetes and its Complications, 29, 8, 1203-1210 Journal of Diabetes and its Complications, 29, 8, 1203-1210 Journal of Diabetes and its Complications, 29, 8, 1203-1210 2015 公開
安原章浩、臼井亮太、岩崎真宏、桑田仁司、渡邊好胤、表孝徳、矢部大介、北谷直美、 古宮俊幸、黒瀬健 安原章浩、臼井亮太、岩崎真宏、桑田仁司、渡邊好胤、表孝徳、矢部大介、北谷直美、 古宮俊幸、黒瀬健 腎機能低下2型糖尿病患者におけるリラグルチドの有効性、安全性および食事療法との関連性の検討 腎機能低下2型糖尿病患者におけるリラグルチドの有効性、安全性および食事療法との関連性の検討 日本病態栄養学会学会誌, 17, 3, 367-375 日本病態栄養学会学会誌, 17, 3, 367-375 , 17, 3, 367-375 2014 公開
Yabe D, Rokutan M, Miura Y, Komoto I, Usui R, Kuwata H, Watanabe K, Hyo T, Kurose T, Nagamatsu T, Shimizu S, Kawai J, Imamura M, Seino Y. Yabe D, Rokutan M, Miura Y, Komoto I, Usui R, Kuwata H, Watanabe K, Hyo T, Kurose T, Nagamatsu T, Shimizu S, Kawai J, Imamura M, Seino Y. Yabe D, Rokutan M, Miura Y, Komoto I, Usui R, Kuwata H, Watanabe K, Hyo T, Kurose T, Nagamatsu T, Shimizu S, Kawai J, Imamura M, Seino Y. Enhanced glucagon-like peptide-1 secretion in a patient with glucagonoma: Implications for glucagon-like peptide-1 secretion from pancreatic α cells in vivo Enhanced glucagon-like peptide-1 secretion in a patient with glucagonoma: Implications for glucagon-like peptide-1 secretion from pancreatic α cells in vivo Enhanced glucagon-like peptide-1 secretion in a patient with glucagonoma: Implications for glucagon-like peptide-1 secretion from pancreatic α cells in vivo Diabetes Research and Clinical Practice, 102, 1 Diabetes Research and Clinical Practice, 102, 1 Diabetes Research and Clinical Practice, 102, 1 2013 公開
Usui R, Yabe D, Kuwata H, Fujiwara S, Watanabe K, Hyo T, Yasuhara A, Iwasaki M, Kitatani N, Kuwabara K, Yokota K, Kurose T, Seino Y. Usui R, Yabe D, Kuwata H, Fujiwara S, Watanabe K, Hyo T, Yasuhara A, Iwasaki M, Kitatani N, Kuwabara K, Yokota K, Kurose T, Seino Y. Usui R, Yabe D, Kuwata H, Fujiwara S, Watanabe K, Hyo T, Yasuhara A, Iwasaki M, Kitatani N, Kuwabara K, Yokota K, Kurose T, Seino Y. Retrospective analysis of safety and efficacy of insulin-to-liraglutide switch in Japanese type 2 diabetes: A caution against inappropriate use in patients with reduced β-cell function Retrospective analysis of safety and efficacy of insulin-to-liraglutide switch in Japanese type 2 diabetes: A caution against inappropriate use in patients with reduced β-cell function Retrospective analysis of safety and efficacy of insulin-to-liraglutide switch in Japanese type 2 diabetes: A caution against inappropriate use in patients with reduced β-cell function Journal of Diabetes Investigation, 4, 6, 585-594 Journal of Diabetes Investigation, 4, 6, 585-594 Journal of Diabetes Investigation, 4, 6, 585-594 2013 公開
Nakatani K, Kurose T, Watanabe K, Matsumoto M, Fujiwara S, Usui R, Kuwata H, Hyo T, Yabe D, Seino Y Nakatani K, Kurose T, Watanabe K, Matsumoto M, Fujiwara S, Usui R, Kuwata H, Hyo T, Yabe D, Seino Y Nakatani K, Kurose T, Watanabe K, Matsumoto M, Fujiwara S, Usui R, Kuwata H, Hyo T, Yabe D, Seino Y Drug-induced generalized itching erythema in diabetes mellitus receiving dipeptidyl peptidase-IV inhibitors plus metformin Drug-induced generalized itching erythema in diabetes mellitus receiving dipeptidyl peptidase-IV inhibitors plus metformin Drug-induced generalized itching erythema in diabetes mellitus receiving dipeptidyl peptidase-IV inhibitors plus metformin Diabetes Therapy, 3, 1, 14 Diabetes Therapy, 3, 1, 14 Diabetes Therapy, 3, 1, 14 2012/12 公開
六反麻里代、矢部大介、臼井亮太、菅原健二、北本友佳、桑田仁司、杉崎和、藤原周一、渡邊好胤、表孝徳、河合潤、細田洋平、粟根雅章、滝吉郎、舘秀和、植田孔明、水野浩、 黒瀬健、清野裕 六反麻里代、矢部大介、臼井亮太、菅原健二、北本友佳、桑田仁司、杉崎和、藤原周一、渡邊好胤、表孝徳、河合潤、細田洋平、粟根雅章、滝吉郎、舘秀和、植田孔明、水野浩、 黒瀬健、清野裕 HbA1c悪化と体重減少を契機に膵癌を含む重複癌が発見された2型糖尿病の一例 HbA1c悪化と体重減少を契機に膵癌を含む重複癌が発見された2型糖尿病の一例 糖尿病, 55, 7, 477-482 糖尿病, 55, 7, 477-482 , 55, 7, 477-482 2012 公開
Rokutan M, Yabe D, Usui R, Sugawara K, Kitamoto Y, Kuwata H, Sugizaki K, Fujiwara S, Watanabe K, Hyo T, Kawai J, Hosoda Y, Awane M, Taki Y, Tachi H, Ueda Y, Mizuno H, Kurose T, Seino Y. Rokutan M, Yabe D, Usui R, Sugawara K, Kitamoto Y, Kuwata H, Sugizaki K, Fujiwara S, Watanabe K, Hyo T, Kawai J, Hosoda Y, Awane M, Taki Y, Tachi H, Ueda Y, Mizuno H, Kurose T, Seino Y. Rokutan M, Yabe D, Usui R, Sugawara K, Kitamoto Y, Kuwata H, Sugizaki K, Fujiwara S, Watanabe K, Hyo T, Kawai J, Hosoda Y, Awane M, Taki Y, Tachi H, Ueda Y, Mizuno H, Kurose T, Seino Y. A case of triple cancer of the pancreas, colon, and peripheral nerve sheath in type 2 diabetes found by progressive body weight loss and deteriorating glycemic control A case of triple cancer of the pancreas, colon, and peripheral nerve sheath in type 2 diabetes found by progressive body weight loss and deteriorating glycemic control A case of triple cancer of the pancreas, colon, and peripheral nerve sheath in type 2 diabetes found by progressive body weight loss and deteriorating glycemic control Journal of the Japan Diabetes Society, 55, 7, 477-482 Journal of the Japan Diabetes Society, 55, 7, 477-482 Journal of the Japan Diabetes Society, 55, 7, 477-482 2012 公開
Iwasaki M, Hoshian F, Tsuji T, Hirose N, Matsumoto T, Kitatani N, Sugawara K, Usui R, Kuwata H, Sugizaki K, Kitamoto Y, Fujiwara S, Watanabe K, Hyo T, Kurose T, Seino Y, Yabe D. Iwasaki M, Hoshian F, Tsuji T, Hirose N, Matsumoto T, Kitatani N, Sugawara K, Usui R, Kuwata H, Sugizaki K, Kitamoto Y, Fujiwara S, Watanabe K, Hyo T, Kurose T, Seino Y, Yabe D. Iwasaki M, Hoshian F, Tsuji T, Hirose N, Matsumoto T, Kitatani N, Sugawara K, Usui R, Kuwata H, Sugizaki K, Kitamoto Y, Fujiwara S, Watanabe K, Hyo T, Kurose T, Seino Y, Yabe D. Predicting efficacy of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Association of glycated hemoglobin reduction with serum eicosapentaenoic acid and docosahexaenoic acid levels Predicting efficacy of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Association of glycated hemoglobin reduction with serum eicosapentaenoic acid and docosahexaenoic acid levels Predicting efficacy of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes: Association of glycated hemoglobin reduction with serum eicosapentaenoic acid and docosahexaenoic acid levels Journal of Diabetes Investigation, 3, 5, 464-467 Journal of Diabetes Investigation, 3, 5, 464-467 Journal of Diabetes Investigation, 3, 5, 464-467 2012 公開

  • <<
  • >>
  • 表示
タイトル言語:
Misc
著者 著者(日本語) 著者(英語) タイトル タイトル(日本語) タイトル(英語) 書誌情報等 書誌情報等(日本語) 書誌情報等(英語) 出版年月 査読の有無 記述言語 掲載種別 公開
後藤久典、臼井亮太、矢部大介 後藤久典、臼井亮太、矢部大介 GLP-1受容体作動薬の心血管・腎イベントリスクに対する効果 GLP-1受容体作動薬の心血管・腎イベントリスクに対する効果 糖尿病の最新治療, 10, 2, 92-98 糖尿病の最新治療, 10, 2, 92-98 , 10, 2, 92-98 2019/02 公開
臼井亮太、矢部大介、黒瀬健、清野裕 臼井亮太、矢部大介、黒瀬健、清野裕 GLP-1受容体作動薬はどのような患者に適していますか? GLP-1受容体作動薬はどのような患者に適していますか? 治療, 96, 6, 988-989 治療, 96, 6, 988-989 , 96, 6, 988-989 2014 公開
臼井亮太、清野裕 臼井亮太、清野裕 長時間作用型GLP-1受容体作動薬(週1回製剤) 長時間作用型GLP-1受容体作動薬(週1回製剤) 糖尿病の最新治療, 5, 1 糖尿病の最新治療, 5, 1 , 5, 1 2013/11 公開
臼井亮太、清野裕 臼井亮太、清野裕 インクレチン関連薬の新薬について―今後,新薬やジェネリックは出てくるのか? インクレチン関連薬の新薬について―今後,新薬やジェネリックは出てくるのか? 糖尿病診療マスター, 11, 3, 290-293 糖尿病診療マスター, 11, 3, 290-293 , 11, 3, 290-293 2013/04 公開
タイトル言語:
講演・口頭発表等
タイトル タイトル(日本語) タイトル(英語) 会議名 会議名(日本語) 会議名(英語) 主催者 主催者(日本語) 主催者(英語) 開催年月日 記述言語 会議種別 公開
The role of the ER Ca2+ sensor, stromal interaction molecule 1 (STIM1), in GPR40-mediated potentiation of glucose-induced insulin secretion The role of the ER Ca2+ sensor, stromal interaction molecule 1 (STIM1), in GPR40-mediated potentiation of glucose-induced insulin secretion The role of the ER Ca2+ sensor, stromal interaction molecule 1 (STIM1), in GPR40-mediated potentiation of glucose-induced insulin secretion 54th Annual Meeting of European Association for the Study of Diabetes 2018 54th Annual Meeting of European Association for the Study of Diabetes 2018 54th Annual Meeting of European Association for the Study of Diabetes 2018 2018/10/01 公開
ER Ca2+ sensor, stromal interaction molecule 1 (STIM1) plays an important role in GPR40-mediated potentiation of glucose-induced insulin secretion ER Ca2+ sensor, stromal interaction molecule 1 (STIM1) plays an important role in GPR40-mediated potentiation of glucose-induced insulin secretion ER Ca2+ sensor, stromal interaction molecule 1 (STIM1) plays an important role in GPR40-mediated potentiation of glucose-induced insulin secretion Asia Islet Biology & Incretin Symposium Asia Islet Biology & Incretin Symposium Asia Islet Biology & Incretin Symposium 2018/08/03 公開
ATP and Ca2+ dynamics in pancreatic β-cells: Ex vivo analysis using ATP biosensor GO-ATeam1 ATP and Ca2+ dynamics in pancreatic β-cells: Ex vivo analysis using ATP biosensor GO-ATeam1 ATP and Ca2+ dynamics in pancreatic β-cells: Ex vivo analysis using ATP biosensor GO-ATeam1 9th Scientific Meeting of the Asian Association for the Study of Diabetes 9th Scientific Meeting of the Asian Association for the Study of Diabetes 9th Scientific Meeting of the Asian Association for the Study of Diabetes 2017/05/20 公開
Long-term efficacy of GLP-1 receptor agonist liraglutide and remaining beta cell function: Retrospective analysis in Japanese patients with type 2 diabetes Long-term efficacy of GLP-1 receptor agonist liraglutide and remaining beta cell function: Retrospective analysis in Japanese patients with type 2 diabetes Long-term efficacy of GLP-1 receptor agonist liraglutide and remaining beta cell function: Retrospective analysis in Japanese patients with type 2 diabetes Asia Islet Biology & Incretin Symposium Asia Islet Biology & Incretin Symposium Asia Islet Biology & Incretin Symposium 2013/11/07 公開
劇症1型糖尿病患者におけるグルカゴン分泌の検討 劇症1型糖尿病患者におけるグルカゴン分泌の検討 第14回日本内分泌学会近畿支部学術集会 第14回日本内分泌学会近畿支部学術集会 2013/10/19 公開
リラグルチド投与がインスリンおよびグルカゴン分泌に及ぼす影響の検討 リラグルチド投与がインスリンおよびグルカゴン分泌に及ぼす影響の検討 第56回 糖尿病学会 年次学術集会 第56回 糖尿病学会 年次学術集会 2013/05/17 公開
Insulin-to-Liraglutide switch in Japanese type 2 diabetes:Efficacy and clinical parameters for discontinuation due to hyperglycemia. Insulin-to-Liraglutide switch in Japanese type 2 diabetes:Efficacy and clinical parameters for discontinuation due to hyperglycemia. Insulin-to-Liraglutide switch in Japanese type 2 diabetes:Efficacy and clinical parameters for discontinuation due to hyperglycemia 9th IDF-WPR Congress & 4th AASD Scientific Meeting 9th IDF-WPR Congress & 4th AASD Scientific Meeting 9th IDF-WPR Congress & 4th AASD Scientific Meeting 2012/11/27 公開
インスリンからリラグルチドへの変更時の効果及び注意点に関する検討 インスリンからリラグルチドへの変更時の効果及び注意点に関する検討 第55回 日本糖尿病学会 年次学術集会 第55回 日本糖尿病学会 年次学術集会 2012/05/17 公開
Efficacy and Safety of Insulin-to-Liraglutide Switch in Management of Type 2 Diabetes in Japanese Efficacy and Safety of Insulin-to-Liraglutide Switch in Management of Type 2 Diabetes in Japanese Efficacy and Safety of Insulin-to-Liraglutide Switch in Management of Type 2 Diabetes in Japanese 3rd Scientific Meeting of the Asian Association for the Study of Diabetes 3rd Scientific Meeting of the Asian Association for the Study of Diabetes 3rd Scientific Meeting of the Asian Association for the Study of Diabetes 2011/07/23 公開
タイトル言語: